Inventor
SHANKER RAVI M
US41 patents
⚠️ This page may combine multiple inventors who share the name “SHANKER RAVI M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BABCOCK WALTER C
10 patentsUS8703196B2Apr 22, 2014
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
BABCOCK WALTER C50 citations97
US8883209B2Nov 11, 2014
Pharmaceutical solid dispersions
BABCOCK WALTER C20 citations92
US8481081B2Jul 9, 2013
Pharmaceutical solid dispersions
BABCOCK WALTER C15 citations92
US8236328B2Aug 7, 2012
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
BABCOCK WALTER C30 citations92
US8257739B2Sep 4, 2012
Pharmaceutical compositions of semi-ordered drugs and polymers
BABCOCK WALTER C6 citations82
US8828442B2Sep 9, 2014
Pharmaceutical solid dispersions
BABCOCK WALTER C2 citations63
US9023393B2May 5, 2015
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
BABCOCK WALTER C3 citations62
US8491933B2Jul 23, 2013
Pharmaceutical compositions of semi-ordered drugs and polymers
BABCOCK WALTER C1 citations50
US8703199B2Apr 22, 2014
Pharmaceutical compositions of adsorbates of amorphous drug
BABCOCK WALTER C0 citations49
US8389006B2Mar 5, 2013
Pharmaceutical compositions of adsorbates of amorphous drug
BABCOCK WALTER C1 citations49
BEND RES INC
10 patentsUS8026286B2Sep 27, 2011
Pharmaceutical compositions providing enhanced drug concentrations
BEND RES INC36 citations96
US8796341B2Aug 5, 2014
Pharmaceutical compositions providing enhanced drug concentrations
BEND RES INC3 citations74
US9468604B2Oct 18, 2016
Pharmaceutical compositions of dispersions of drug and neutral polymers
BEND RES INC3 citations72
US10357455B2Jul 23, 2019
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
BEND RES INC3 citations70
US8980321B2Mar 17, 2015
Pharmaceutical compositions providing enhanced drug concentrations
BEND RES INC2 citations63
US8048452B2Nov 1, 2011
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
BEND RES INC2 citations62
US7897175B2Mar 1, 2011
Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
BEND RES INC2 citations59
USRE47033ESep 11, 2018
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
BEND RES INC0 citations52
US9457095B2Oct 4, 2016
Pharmaceutical compositions providing enhanced drug concentrations
BEND RES INC0 citations52
US9445998B2Sep 20, 2016
Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
BEND RES INC0 citations38
PFIZER
7 patentsUS6548555B1Apr 15, 2003
Basic drug compositions with enhanced bioavailability
PFIZER123 citations97
US6399777B2Jun 4, 2002
Inclusion complexes of aryl-heterocyclic salts
PFIZER14 citations92
US6232304B1May 15, 2001
Inclusion complexes of aryl-heterocyclic salts
PFIZER36 citations92
US7235259B2Jun 26, 2007
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
PFIZER8 citations73
US6124457ASep 26, 2000
Process and intermediates for a β3 -adrenergic receptor agonist
PFIZER13 citations72
US6090942AJul 18, 2000
Process and intermediates for a β3 -adrenergic receptor agonist
PFIZER6 citations72
US11065250B2Jul 20, 2021
Solid dosage forms of palbociclib
PFIZER1 citations51
DURECT CORP
5 patentsUS9572885B2Feb 21, 2017
Compositions with a rheological modifier to reduce dissolution variability
DURECT CORP8 citations83
US9555113B2Jan 31, 2017
Compositions with a rheological modifier to reduce dissolution variability
DURECT CORP5 citations83
US9855333B2Jan 2, 2018
Compositions with a rheological modifier to reduce dissolution variability
DURECT CORP2 citations72
US10300142B2May 28, 2019
Compositions with a rheological modifier to reduce dissolution variability
DURECT CORP0 citations51
US9907851B2Mar 6, 2018
Compositions with a rheological modifier to reduce dissolution variability
DURECT CORP0 citations51
CURATOLO WILLIAM J
3 patentsUS8202912B2Jun 19, 2012
Pharmaceutical compositions providing enhanced drug concentrations
CURATOLO WILLIAM J29 citations96
US8501231B2Aug 6, 2013
Pharmaceutical compositions providing enhanced drug concentrations
CURATOLO WILLIAM J5 citations84
US7115279B2Oct 3, 2006
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
CURATOLO WILLIAM J13 citations83